RT Journal Article SR Electronic T1 D2 Lymphadenectomy in Gastric Cancer Surgery JF Clinical Oncology and Cancer Research JO Cancer Biol Med FD China Anti-Cancer Association SP 162 OP 168 DO 10.1007/s11805-009-0162-3 VO 6 IS 3 A1 Deng, Jingyu A1 Liang, Han YR 2009 UL http://www.cancerbiomed.org/content/6/3/162.abstract AB Gastric cancer is one of the most common causes of cancer death worldwide. Surgery is the most widely utilized treatment for resectable gastric cancer. Evidence indicates that lymph node involvement and depth of invasion of the primary tumor are the most important prognostic factors for gastric cancer patients. Therefore, lymph node clearance is deemed a key procedure in gastric cancer surgery for the prognostic value to patients. Although the appropriate lymphadenectomy during gastrectomy for cancer still remains controversial, extended lymph node dissection (D2 lymphadenectomy) should be recommended in high volume hospitals.